If you’re having trouble sleeping on a regular basis, you may have an underlying sleep disorder that a sleep specialist could help diagnose and manage.
“Non-pharmacological interventions have long-term, long-standing data that proves their safety and efficacy,” Conroy says. “I know CBD oil for the treatment of sleep disorders is intriguing, but we’re looking for answers we just don’t have yet. The products are outpacing the science.”
Similar to THC though, CBD can help you relax and people are wondering if it will help them finally get some good shut eye.
Having outlets for managing stress and anxiety, like journaling or seeking professional help with a therapist if it’s more serious.
Setting yourself up for sleep
“It’s a tricky question to answer,” says Deirdre Conroy, Ph.D. , clinical director of the Behavioral Sleep Medicine Clinic at Michigan Medicine. “There have been few studies on CBD and its effect on sleep, and those published have few participants with differing doses and forms of CBD administered.”
Melatonin for sleep , like CBD, needs more research to unmask its benefits and harms. “We secrete melatonin naturally as our bodies prepare for bed,” Conroy says. “I believe in harnessing what you already have.”
However, many of these studies suggest there could be some benefit to using CBD as a sleep aid, and it’s worth researching. “For example, there’s evidence that CBD can be helpful in managing anxiety . If someone’s anxiety is creating their sleeping problem, a CBD product may benefit them,” Conroy says.
Like Podcasts? Add the Michigan Medicine News Break to your Alexa-enabled device or subscribe for daily updates on iTunes , Google Play and Stitcher .
But reaping the rewards of CBD is a slippery slope since much of its long term safety or efficacy is still unknown. One study showed taking less than 160 mg of CBD oil may actually promote wakefulness . While higher doses can promote sleep, the FDA has approved only one CBD product, a prescription drug to treat two rare, severe forms of epilepsy. Because other CBD products aren’t regulated, you might not know what you’re really getting.
These results demonstrated a more sustained response to anxiety than for sleep over time. Patient records displayed a larger decrease in anxiety scores than in sleep scores. The sleep scores demonstrated mild improvement. The anxiety scores decreased within the first month and then remained decreased during the study duration.
To determine whether CBD helps improve sleep and/or anxiety in a clinical population.
HAM-A = Hamilton Anxiety Rating Scale; PSQI = Pittsburg Sleep Quality Index.
CBD was well tolerated, with few patients reporting side effects. Two patients discontinued treatment within the first week because of fatigue. Three patients noted mild sedation initially that appeared to abate in the first few weeks. One patient with a developmental disorder (aged 21 years) had to be taken off the CBD regimen because of increased sexually inappropriate behavior. The CBD was held, and the behavior disappeared. The behavior reappeared on redosing 2 weeks later, and the CBD regimen was formally discontinued. The treating psychiatrist thought this was related to disinhibition because the patient’s anxiety responded dramatically. One patient noted dry eyes. Reasons for patients not following-up at later assessment points are largely unknown but are probably because of standard attrition experienced in usual clinical practice. There was no evidence to suggest patients discontinued care because of tolerability concerns. The attrition rates were similar in nature and size to those found in routinely scheduled visits in this clinic.
The treatment with CBD was in general well accepted, as judged by the clinicians’ and patients’ responses. Four patients declined CBD treatment because of religious or ethical concerns about the relation to cannabis. Nearly all patients easily provided informed consent once the nature of the treatment was explained. Most patients appreciated the opportunity to try something natural and avoid further or initial psychiatric medication use.
Mean anxiety and sleep scores for adults using cannabidiol treatment.
Table 1 provides means and standard deviations for sleep and anxiety scores at baseline and during the follow-up period for adults taking CBD. Figure 1 graphically displays the trend in anxiety and sleep scores over the study period. On average, anxiety and sleep improved for most patients, and these improvements were sustained over time. At the first monthly assessment after the start of CBD treatment, 79.2% (57/72) and 66.7% (48/72) of all patients experienced an improvement in anxiety and sleep, respectively; 15.3% (11/72) and 25.0% (18/72) experienced worsening symptoms in anxiety and sleep, respectively. Two months after the start of CBD treatment, 78.1% (32/41) and 56.1% (23/41) of patients reported improvement in anxiety and sleep, respectively, compared with the prior monthly visit; again, 19.5% (8/41) and 26.8% (11/41), respectively, reported worsening problems as compared with the prior month.
HAM-A = Hamilton Anxiety Rating Scale; PSQI = Pittsburg Sleep Quality Index; SD = standard deviation.